FSTX logo

F-star Therapeutics (FSTX) Operating Profit

Annual Operating Profit

-$30.71 M
-$8.84 M-40.39%

December 31, 2021


Summary


Performance

FSTX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXprofitabilitymetrics:

Quarterly Operating Profit

-$13.71 M
+$2.48 M+15.30%

September 30, 2022


Summary


Performance

FSTX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXprofitabilitymetrics:

TTM Operating Profit

-$36.75 M
-$4.11 M-12.57%

September 30, 2022


Summary


Performance

FSTX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

FSTX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.4%-42.8%+15.5%
3 y3 years-67.4%-161.9%-602.2%
5 y5 years-67.4%-161.9%-602.2%

FSTX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-417.0%+18.1%+19.7%at low
5 y5-year+67.4%at low-417.0%+18.1%+602.2%+18.4%
alltimeall time+67.4%at low-417.0%+18.1%+602.2%+18.4%

F-star Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sep 2022
-
-$13.71 M(-15.3%)
-$36.75 M(+12.6%)
Jun 2022
-
-$16.18 M(+44.6%)
-$32.65 M(+4.4%)
Mar 2022
-
-$11.19 M(-358.8%)
-$31.26 M(+1.8%)
Dec 2021
-$30.71 M
$4.32 M(-145.0%)
-$30.71 M(-29.4%)
Sep 2021
-
-$9.60 M(-35.1%)
-$43.51 M(+16.7%)
Jun 2021
-
-$14.79 M(+39.0%)
-$37.29 M(+36.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$10.64 M(+25.7%)
-$27.29 M(+24.7%)
Dec 2020
-$21.88 M(+19.3%)
-$8.47 M(+150.1%)
-$21.88 M(+63.2%)
Sep 2020
-
-$3.39 M(-29.2%)
-$13.41 M(+33.8%)
Jun 2020
-
-$4.79 M(-8.6%)
-$10.02 M(+91.4%)
Mar 2020
-
-$5.23 M
-$5.23 M
Dec 2019
-$18.34 M
-
-

FAQ

  • What is F-star Therapeutics annual operating income?
  • What is the all time high annual operating profit for F-star Therapeutics?
  • What is F-star Therapeutics annual operating profit year-on-year change?
  • What is F-star Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for F-star Therapeutics?
  • What is F-star Therapeutics quarterly operating profit year-on-year change?
  • What is F-star Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for F-star Therapeutics?
  • What is F-star Therapeutics TTM operating profit year-on-year change?

What is F-star Therapeutics annual operating income?

The current annual operating profit of FSTX is -$30.71 M

What is the all time high annual operating profit for F-star Therapeutics?

F-star Therapeutics all-time high annual operating income is -$18.34 M

What is F-star Therapeutics annual operating profit year-on-year change?

Over the past year, FSTX annual operating income has changed by -$8.84 M (-40.39%)

What is F-star Therapeutics quarterly operating income?

The current quarterly operating profit of FSTX is -$13.71 M

What is the all time high quarterly operating profit for F-star Therapeutics?

F-star Therapeutics all-time high quarterly operating income is $4.32 M

What is F-star Therapeutics quarterly operating profit year-on-year change?

Over the past year, FSTX quarterly operating income has changed by -$4.11 M (-42.76%)

What is F-star Therapeutics TTM operating income?

The current TTM operating profit of FSTX is -$36.75 M

What is the all time high TTM operating profit for F-star Therapeutics?

F-star Therapeutics all-time high TTM operating income is -$5.23 M

What is F-star Therapeutics TTM operating profit year-on-year change?

Over the past year, FSTX TTM operating income has changed by +$6.76 M (+15.53%)